健康系统专科药师对多发性硬化患者的干预类型与接受率
该回顾性多中心描述性研究分析了2019年10月至2022年8月225名多发性硬化患者接受的449次药师干预,平均每人2.0次。干预主要涉及用药依从性(28.7%)、用药方案(27.6%)、药物不良反应(20.7%)和实验室检查(15.1%),建议接受率为85.3%。
要点
- 药师干预最常见于用药依从性、用药方案和药物不良反应管理。
- 药师建议的总体接受率为85.3%,仅3.8%被拒绝。
- 平均依从性(按覆盖天数比例)为94%。
核心结论
- 药师通过完成临床干预改善多发性硬化患者的依从性、识别用药方案问题、管理药物不良反应并协调实验室检查,从而影响患者结局。
研究设计与样本
- 回顾性、多中心、观察性、描述性研究,纳入2019年10月至2022年8月期间225名接受健康系统专科药学服务的多发性硬化患者,共完成449次干预。
主要发现
- 干预类型分布:用药依从性28.7%,用药方案27.6%,药物不良反应20.7%,实验室检查值15.1%。
- 平均依从性(覆盖天数比例)为94%。
- 最常见建议为继续治疗(14.9%)、安排实验室检查(12.7%)和随访提供者(11.8%)。
- 建议接受率为85.3%,3.8%被拒绝,10.9%需要随访提供者。
临床怎么用
- 药师应重点关注多发性硬化患者的用药依从性、用药方案优化、药物不良反应管理和实验室监测协调。
- 针对用药方案和药物不良反应的干预建议接受率较高,可优先开展此类药学服务。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Health-system specialty pharmacy (HSSP) pharmacists play an integral role in the care of patients with multiple sclerosis (PwMS) by facilitating medication access, providing counseling, improving adherence, and decreasing provider workload. However, current literature detailing pharmacist interventions and their acceptance rates in this population is limited. The purpose of this study was to identify the types and acceptance rate of clinical interventions completed by pharmacists for PwMS. METHODS: To evaluate the acceptance rate of HSSP pharmacist interventions, we conducted a retrospective, multicenter, observational, descriptive study for the period from October 2019 to August 2022. Intervention types were categorized into reasons for intervention, recommendations from the pharmacists, and their acceptance rates. RESULTS: For 225 patients enrolled in HSSP services, 449 interventions were completed, with an average of 2.0 interventions per patient. Most interventions identified were associated with medication adherence (28.7%), medication regimen (27.6%), adverse drug reaction (ADR) (20.7%), and laboratory values (15.1%). The average adherence, defined by the proportion of days covered, was 94%. The most common recommendations were to continue therapy (14.9%), schedule laboratory tests (12.7%), and follow up with providers (11.8%). Recommendations had an acceptance rate of 85.3%, with 3.8% of recommendations declined and 10.9% requiring follow-up with providers. CONCLUSION: Pharmacists impact patient outcomes through the completion of clinical interventions that improve adherence, identify medication regimen problems, manage ADRs, and coordinate proper laboratory testing. Pharmacist recommendations were most often accepted for interventions related to medication regimen and ADRs. Proper identification and management of medication regimen concerns, as well as tolerability of medications, can positively impact adherence and improve overall patient outcomes.
引用
- El-Khouri AC, Giavatto C, Hickman A, et al. Health-system specialty pharmacist intervention types, acceptance, and associated actions for patients with multiple sclerosis. Am J Health Syst Pharm. 2024. PMID: 38298009. doi:10.1093/ajhp/zxae024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。